CureZone
Old Format -> CureZone.INFO
Home > Knowledge Base > Cancer > > Uterine Sarcoma
Sponsored Ads

Toxic Laundry Detergent?
Find out the hidden toxic chemical that is inside your laundry det...


Erectile Dysfunction?
Combat ED without pills, from home. Guaranteed 100% Success


What is Nascent Iodine?
What is Nascent Iodine? How does it work? Click to learn Iodine¡¯s ...


Find Real Cure!
New Holistic Medicine


____________

Protozoa, Amoeba, Pin Worms?
Hulda Clark Cleanses


Official Dr. Clark Video Database
Sign Up Once And Get Instant Access Forever


Iodine Supports Thyroid Health
#1 Rated Iodine Supplement! 180-Day Money Back Guarantee. Fr...


Your Ad Here
Place your ad here !


____________

Natural Cancer Remedies


Rose Laurel OPC Capsules
15% Off With Curezone Discount Code Of Lr001


Destroy Parasites Quickly
Learn How to Destroy Parasites And Be Free of Your Unbearable Sym...


____________

Lugol’s Iodine Free S&H
J.Crow’s® Lugol’s Iodine Solution. Restore lost reserves.


Tbyil Supplement Catalog
The Best Years in Life’s hand picked top quality natural health co...


Become a Sponsor
Antineoplastons - Burzynski Therapy
Knowledge Base > Cancer > > Uterine Sarcoma
 
 [Answer This Question]   [Ask New Question]   Click here to receive email notification every time someone answers this question
Antineoplastons are nontoxic substances that have shown to be a promising therapy for difficult-to-treat brain cancers  by #56153   10 year
 

Burzynski Research Institute
Stanislaw R. Burzynski, MD, PhD
www.cancermed.com

9432 Old Katy Rd, Suite 200
Houston, TX  77055-6330
713-335-5697 or fax 713-335-5699
info@burzynskiclinic.com

Dr. Burzynski discovered peptides and amino acid derivatives in the human body that control cancer, not by destroying cancer cells but by correcting them. He named these substances antineoplastons. 

Antineoplastons are nontoxic substances that have shown to be a promising therapy for difficult-to-treat brain cancers, low- and intermediate-grade non-Hodgkin's lymphoma, and many common types of solid tumors. Note: Antineoplastons have not been approved by the Food and Drug Administration as safe and effective for the treatment of any disease or condition. However, clinical trials are under way on this treatment.

Dr. Burzynski has been approved by the Food and Drug Administration as Principal Investigator in over 70 clinical trial studies. These studies encompass a wide range of cancer types in both children and adults. However, he is best known for treating brain cancer.

After 25 years of experimentation, the outlook for antineoplastons in the treatment of cancer has never been brighter. However, Dr. Burzynski advises that the treatment is still considered experimental, and that no promises of effectiveness can be made.

All residents of the United States must participate and be treated under a current FDA-approved clinical trial or Special Exception. Residents of most other countries must receive FDA permission to ship antineoplastons to that country. All patients are treated on an outpatient basis. The treatment is self-administered and normally free of serious side effects.

Currently there is legislation underway to allow for choice of therapy in treating ones cancer that resulted from Thomas Navarro being denied treatment at Burzynski's clinic.

Mechanism of Action

Dr. Burzynski sees cancer as a disease of cellular information processing. Antineoplastons seem to correct the program inside the cell and can change a cancerous cell back to a normal cell. Dr. Burzynski described a study carried out at the Department of Pathology for the Department of Defense in Bethesda, Maryland. The study showed that using antineoplaston AS2-1 in tissue culture caused cancer cells to change back into normal cells after approximately two to three days. (1)

Healthy cells specialize as they develop. After a specific number of cellular divisions, these specialized cells are programmed to die. Cancer cells, due to incorrect programming, undergo uncontrolled cellular proliferation. They keep multiplying without limit until they finally kill the patient. Dr. Burzynski has postulated that antineoplastons reprogram cancer cells so they behave like normal cells, with a limited life span.

The antineoplastons have to be administered continually and for a long enough time to allow the previously cancerous cells to go through their life cycle to cellular death. If the therapy is slowed down or stopped too soon, the cell (which still has an incorrect program) will start behaving like a cancerous cell again.

Since antineoplastons occur normally in humans but are present in low levels in cancer patients, Dr. Burzynski believes that testing the level of antineoplastons can be used to diagnose cancer in the future.

http://www.cancermed.com/

http://www.cancerguide.org/antineoplaston.html

http://www.mnwelldir.org/docs/history/biographies/burzynski.htm

http://www.ouralexander.org/burzynski.htm

 

Good Answer? Yes     No       Hide this question

Viewed 148306 times
All #56153's Answers
Terms of Service



 


 

Donate to CureZone

 


Share:  Facebook  MySpace  Digg  Reddit  StumbleUpon  Furl this page  Delicious  BlinkList  dzone  Simpy.com  Fark.com  BlogMarks  Wists.com  Google
Translate This Page:

Medianet Ads

Terms of Service - Privacy Policy - Spam Policy - Disclaimer - Guidelines & Rules

CureZone Newsletter is distributed in partnership with www.netatlantic.com


Contact Us - About - Advertise - Stats

Copyright 1999 - 2015  www.curezone.org

0.125 sec, (1)